Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Free Cash Flow (2018 - 2025)

Exagen's Free Cash Flow history spans 8 years, with the latest figure at -$3.6 million for Q4 2025.

  • For Q4 2025, Free Cash Flow fell 24346.67% year-over-year to -$3.6 million; the TTM value through Dec 2025 reached -$14.3 million, down 1.93%, while the annual FY2025 figure was -$14.3 million, 1.93% down from the prior year.
  • Free Cash Flow reached -$3.6 million in Q4 2025 per XGN's latest filing, down from $2.9 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $8.2 million in Q4 2023 to a low of -$13.1 million in Q2 2022.
  • Average Free Cash Flow over 5 years is -$5.0 million, with a median of -$4.6 million recorded in 2021.
  • Peak YoY movement for Free Cash Flow: surged 234.25% in 2023, then plummeted 24346.67% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at -$4.8 million in 2021, then fell by 28.16% to -$6.1 million in 2022, then soared by 234.25% to $8.2 million in 2023, then crashed by 99.82% to $15000.0 in 2024, then tumbled by 24346.67% to -$3.6 million in 2025.
  • Per Business Quant, the three most recent readings for XGN's Free Cash Flow are -$3.6 million (Q4 2025), $2.9 million (Q3 2025), and -$2.8 million (Q2 2025).